News

Cytokines are small proteins produced by cells that regulate immune and inflammatory responses to various stimuli, including infection and cancer. Therefore, cytokine screening has significant value in clinical medicine as the cytokine pattern profile provide insight into disease processes that can be used to aid in diagnosis and treatment. The use of protein arrays for…

Come and meet our team at BioCHIP. booth#1919.

Antibody arrays continue to grow in popularity. Know more about antibody microarrays in this Biocompare’s editorial in which our expert took part.

Innopsys and all its team wish you a wonderful year 2022!  

Come and meet our team at Medica Hall 3, Stand 72. We will be glad to present our latest technology.  

Venez-nous rendre visite durant la SFNC 2021 à Nice! Nous vous présenterons notre gamme i-Care pour la Neurostimulation et l’ElectroMyographie (EMG).    

We’re excited to be attending the virtual #EANS2021 congress and Professor Hugues Duffau diner symposium regarding “Awake surgery for low-grade glioma, a connectome-based resection: How I do it.” On Wednesday, October 6, 17:10-18:10.

Cancer is a complex degenerative disease needing for rapid and precise diagnosis. Cancer disease is characterized by heterogeneous and changing phenotypes continuously progressing through different clinical stages. As a global approach, personalized medicine aims at integrating diagnosis with therapy. To do so, it is necessary to get as much information as possible about patient genetics…

Innopsys will attend to MEDICA 2021 show from November 15th to November 18th. Find us Hall 3.  

Innopsys is proud to announce the commercial partnering with Sysmex Spain for the commercialization of a full package including the CytoSure aCGH arrays and the InnoScan scanners. This collaboration takes place as part of a longtime patterning with Oxford Gene Technology, and corroborates the use of the InnoScan scanners as the first choice to scan…